2.2 Anemia of Chronic Inflammation, Sideroblastic Anemias & Lead Toxicity

Anemia of Chronic Inflammation, Sideroblastic Anemias & Lead Toxicity

Not every microcytic or hypochromic anemia is caused by a lack of iron. Three disorders reproduce parts of the iron deficiency picture while requiring completely different management: anemia of chronic inflammation, in which iron is abundant but sequestered; the sideroblastic anemias, in which iron reaches the mitochondrion but cannot be inserted into protoporphyrin IX; and lead toxicity, in which two heme-pathway enzymes and a nucleotide-degrading enzyme are poisoned simultaneously. The ASCP BOC tests these as a differential set, so learn the iron studies and the marrow iron stain findings side by side.

---

Anemia of Chronic Disease / Chronic Inflammation (ACD/ACI)

Anemia of Chronic Disease (also termed Anemia of Chronic Inflammation) is the second most prevalent anemia worldwide and the most common anemia among hospitalized patients. It accompanies chronic systemic infections (tuberculosis, osteomyelitis, HIV, subacute bacterial endocarditis), autoimmune and rheumatologic disorders (rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease), and solid or hematologic malignancies.

Pathophysiological Mechanisms

• Hepcidin Hypersecretion: Macrophages and T-cells release inflammatory cytokines (IL-6, TNF-$\alpha$, IL-1, IFN-$\gamma$). IL-6 directly stimulates hepatocyte transcription of hepcidin via the STAT3 pathway. High hepcidin levels degrade ferroportin, trapping iron in the macrophage storage compartment.
• Impaired Iron Mobilization & Hypoferremia: Despite rich total-body iron stores, iron cannot be released to apotransferrin. Erythroid progenitors become iron-starved amidst abundant storage iron ("iron entrapment syndrome").
• Blunted Erythropoietin Response: TNF-$\alpha$ and IFN-$\gamma$ directly suppress renal peritubular EPO gene expression, blunting the expected compensatory EPO surge. Furthermore, these cytokines release reactive oxygen species that induce direct apoptosis of CFU-E and BFU-E erythroid colonies.
• Shortened Erythrocyte Lifespan: Non-specific hyperactivation of reticuloendothelial macrophages accelerates premature destruction of normal circulating red blood cells (shortening lifespan by 20–30%).

Laboratory Hallmarks & Differentiation from IDA

• Serum Iron: Decreased (typically $20\text{ to }50\text{ }\mu\text{g/dL}$).
• TIBC: Normal to Decreased ($100\text{ to }250\text{ }\mu\text{g/dL}$) because transferrin is a negative acute-phase reactant whose hepatic synthesis is downregulated during systemic inflammation.
• Transferrin Saturation: Low to normal (typically $10%\text{ to }20%$).
• Serum Ferritin: Normal to Significantly Elevated ($100\text{ to }1000+\text{ ng/mL}$) because ferritin is a positive acute-phase reactant upregulated by cytokines.
• Soluble Transferrin Receptor (sTfR): Normal in uncomplicated ACD (erythroblasts do not upregulate TfR1 because inflammation suppresses erythropoiesis), whereas sTfR is significantly elevated in IDA. The sTfR / $\log_{10}$ Ferritin Index ($<1.0$ in ACD; $>2.0$ in IDA or combined IDA/ACD) is an essential diagnostic discriminator.
• Bone Marrow Findings: Prussian blue staining reveals abundant coarse hemosiderin aggregates inside marrow macrophages, but an absence or severe depletion of iron granules within developing normoblasts (sideroblasts $<10%$, normal is $30%\text{ to }50%$).

---

Sideroblastic Anemias

Sideroblastic anemias represent a heterogeneous group of disorders characterized by defective mitochondrial protoporphyrin and heme synthesis. Because iron enters developing erythroblasts normally via transferrin endocytosis but cannot be incorporated into the protoporphyrin IX ring, excess iron accumulates inside the inner mitochondrial matrix.

Normal Erythroblast Mitochondria:        Sideroblastic Anemia Mitochondria:
Protoporphyrin IX + Fe²⁺ ──► Heme        Defective Porphyrin Synthesis ──► Fe²⁺ Accumulation
(Iron utilized & dispersed)              (Iron aggregates in perinuclear mitochondria)
                                         ═════════════════════════════════════════════════
                                         Prussian Blue: Ring Sideroblast (≥5 iron granules
                                         encircling ≥1/3 of the nuclear circumference)

Hereditary vs. Acquired Etiologies

1. Hereditary Sideroblastic Anemia:
   • X-linked Sideroblastic Anemia (XLSA): The most common inherited form, caused by loss-of-function mutations in the $ALAS2$ gene (Xp11.21), which encodes erythroid-specific 5-aminolevulinate synthase. $ALAS2$ catalyzes the initial and rate-limiting step of heme synthesis (condensation of glycine and succinyl-CoA to form $\delta$-aminolevulinic acid) and requires pyridoxal 5'-phosphate (vitamin $B_6$) as a cofactor. Patients often demonstrate partial responsiveness to high-dose pyridoxine therapy.
   • Autosomal recessive forms involve mutations in mitochondrial transporter genes such as SLC25A38 or mitochondrial iron-sulfur cluster assembly machinery (ABCB7, GLRX5).
2. Acquired Sideroblastic Anemia:
   • Clonal / Neoplastic (MDS-RS): Myelodysplastic Syndrome with Ring Sideroblasts, strongly associated with somatic mutations in the $SF3B1$ gene (splicing factor 3b subunit 1) or other RNA spliceosome machinery, leading to mitochondrial iron handling failure.
   • Reversible / Toxic-Metabolic:
     • Chronic Alcohol Abuse: Ethanol acts as a direct mitochondrial toxin that suppresses $ALAS2$, ferrochelatase, and pyridoxal kinase activity.
     • Medications: Isoniazid (INH), an anti-tubercular agent that antagonizes pyridoxal phosphate; chloramphenicol and linezolid, which inhibit mitochondrial ribosome translation.
     • Copper Deficiency / Zinc Toxicity: Copper is required for ceruloplasmin/hephaestin and cytochrome c oxidase; excess zinc ingestion (e.g., denture creams) upregulates enterocyte metallothionein, which traps copper and prevents its absorption.

The Ring Sideroblast & Prussian Blue Iron Stain

A ring sideroblast is an abnormal erythroid precursor (normoblast) identified on bone marrow aspirate smears stained with Prussian blue (Perls' acid ferrocyanide). The diagnostic criteria require 5 or more siderotic iron granules encircling at least one-third ($\ge 1/3$) of the nuclear circumference. These granules correspond ultrastructurally to iron-overloaded, swollen mitochondria hugging the outer nuclear envelope.

Peripheral Smear & Laboratory Profile

• Dimorphic RBC Population: A hallmark feature visible on peripheral blood smears and reflected in a markedly elevated RDW. The smear exhibits two distinct erythrocyte populations: microcytic hypochromic cells (from defective clones) and normocytic normochromic cells (or macrocytes in MDS).
• Pappenheimer Bodies (Siderotic Granules): Distinct, small, dense, dark-purple irregular inclusions located at the cell periphery on Wright-Giemsa stain. Composed of iron aggregates complexed with protein, they turn vivid blue-green when confirmed with Prussian blue stain.
• Iron Studies Profile: Demonstrates marked systemic iron overload due to ineffective erythropoiesis suppressing hepcidin: markedly elevated serum iron, normal to low TIBC, high transferrin saturation (>50–80%), and markedly elevated serum ferritin (>500–1500 ng/mL).

---

Lead Poisoning (Plumbism)

Lead is a potent environmental heavy metal toxin that causes multi-organ pathology, encephalopathy, abdominal colic, peripheral motor neuropathy (wrist drop/foot drop), and a characteristic microcytic or normocytic anemia.

Molecular Enzymatic Disruptions

1. Inhibition of $\delta$-Aminolevulinic Acid Dehydratase ($\delta$-ALAD / Porphobilinogen Synthase): Lead displaces essential zinc ions from $\delta$-ALAD, blocking the condensation of two $\delta$-ALA molecules into porphobilinogen (PBG). This leads to marked accumulation and urinary excretion of $\delta$-aminolevulinic acid (ALA).
2. Inhibition of Ferrochelatase (Heme Synthase): Lead directly poisons the mitochondrial enzyme ferrochelatase, preventing the final insertion of ferrous iron ($Fe^{2+}$) into protoporphyrin IX. Unchelated protoporphyrin IX combines non-enzymatically with zinc to form Zinc Protoporphyrin (ZPP), which fluoresces under ultraviolet light.
3. Inhibition of Pyrimidine 5'-Nucleotidase: Lead inhibits pyrimidine 5'-nucleotidase, the enzyme responsible for clearing digested ribosomal ribonucleic acid (rRNA) during reticulocyte maturation. Undegraded rRNA aggregates into visible cytoplasmic precipitates.

                      Heme Biosynthesis Pathway Disruptions in Lead Toxicity

Succinyl-CoA + Glycine
         │
         │  (ALAS2 - Requires Pyridoxal 5'-Phosphate / Vit B6)
         ▼
   δ-ALA (delta-Aminolevulinic Acid)
         │
         ├───────────────────────────► [BLOCKED BY LEAD] ──► ↑ Urinary δ-ALA
         │  (δ-ALAD / Zinc-Dependent)
         ▼
   Porphobilinogen (PBG)
         │
         ▼  ...
   Protoporphyrin IX + Fe²⁺
         │
         ├───────────────────────────► [BLOCKED BY LEAD] ──► ↑ Free Erythrocyte Protoporphyrin (FEP)
         │  (Ferrochelatase)                                 ↑ Zinc Protoporphyrin (ZPP)
         ▼
       HEME

Hematologic Morphology & Diagnostic Testing

• Coarse Basophilic Stippling: The diagnostic morphologic hallmark on Wright-Giemsa stained peripheral blood smears. Appears as numerous coarse, punctate, deep-blue granules distributed evenly throughout the entire erythrocyte cytoplasm, representing precipitated ribosomal RNA aggregates.
• Whole Blood Lead Level (BLL): The definitive gold-standard confirmatory test (diagnostic threshold in children $\ge 3.5\text{ }\mu\text{g/dL}$ per CDC guidelines; toxic manifestations typically appear $>20\text{ to }45\text{ }\mu\text{g/dL}$).
• Erythrocyte Protoporphyrin (FEP / ZPP): Markedly elevated, serving as a durable indicator of prolonged cellular toxicity.

---

Comparative Differential Diagnosis of Microcytic Hypochromic Anemias

The following clinical laboratory matrix summarizes the critical biochemical and morphologic parameters required to distinguish microcytic hypochromic disorders on the ASCP BOC examination: